Zenas BioPharma, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveSep 8 →Insiders11 insiders bought $29.0M in 25 open-market buys. No sales.→HoldersFMR 15.0%SR One 8.0%Nea 6.4%→Financing →PeersClosest companies: SLS, ROIV, APGE→
From the filings
Figures
- Revenue
- $10.0Mlast 12 months
- Net income
- −$484.4Mlast 12 months
- Operating cash flow
- −$210.5Mlast 12 months
- Cash and equivalents
- $196.6Mat the last balance sheet
- Total debt
- $78.6Mat the last balance sheet
- Shares outstanding
- 63.3M shareson issue